GeneDx J.P. Morgan 2026 Healthcare Conference Presentation.pdf

1、GeneDx Nasdaq:WGSJ.P.Morgan Healthcare ConferenceJanuary 2026San Francisco,California2Forward-Looking StatementsThis presentation contains“forward-looking statements”within the meaning of Section 21E of the Securities Exchange Act of 1934,as amended,and the U.S.Private Securities Litigation Reform A

2、ct of 1995,including statements regarding our future performance and our market opportunity,including our expected full year 2025 reported revenue,fourth quarter and full year 2025 adjusted gross margin,and growth in exome and genome revenue and test result volumes and,expectations for full year 202

3、6 revenue,exome and genome revenue and test volumes,adjusted gross margin and adjusted net income.These forward-looking statements generally are identified by the words“believe,”“project,”“expect,”“anticipate,”“estimate,”“intend,”“strategy,”“future,”“opportunity,”“plan,”“may,”“should,”“will,”“would,

4、”“will be,”“will continue,”“will likely result,”and similar expressions.Forward-looking statements are predictions,projections and other statements about future events that are based on current expectations and assumptions and,as a result,are subject to risks and uncertainties.Many factors could cau

5、se actual future events to differ materially from the forward-looking statements in this presentation,including but not limited to:(i)our ability to implement business plans,goals and forecasts,and identify and realize additional opportunities,(ii)the risk of downturns and a changing regulatory land

6、scape in the highly competitive healthcare industry,(iii)the size and growth of the market in which we operate,and(iv)our ability to pursue our new strategic direction.The foregoing list of factors is not exhaustive.A further list and description of risks,uncertainties and other matters can be found